Early outcome of patients with rheumatoid arthritis treated with infliximab
Journal Title: Reumatologia - Year 2006, Vol 44, Issue 3
Abstract
The aim of this study was to analyse the outcome of patients with rheumatoid arthritis (RA) treated with infliximab. Thirty-one patients (3 male, 28 female), aged 50 years (range 22-67 years), treated in a single institution between 2001-2003 were included. For the purpose of this study, RA activity was analysed at baseline, after 23 weeks (i.e. after 5 infusions), and after 54 weeks (i.e. after 9 infusions). Twenty-one (68%) patients achieved good response according to EULAR criteria after both 23 and 54 weeks of therapy. None of the patients who failed to respond after 23 weeks responded after 54 weeks. None of the analysed factors (age, sex, disease duration, number of preceding disease-modifying anti-rheumatic drugs) was found to influence the probability to achieve good response. Our results indicate high efficacy of infliximab in the treatment of RA. They also suggest that the treatment protocol could further be rationalised.
Authors and Affiliations
Aleksandra Zoń-Giebel, Wiesława Liwoch-Morżoł, Janina Witkowska-Tomiczek, Andrzej Banasik, Piotr Sikora, Eugeniusz Zielonka, Danuta Kapołka
Keywords
Related Articles
- EP ID EP133891
- DOI -
- Views 57
- Downloads 0
Ocular manifestations in rheumatoid arthritis
Rheumatoid arthritis is present in 0.5 to 3% of adult population and ocular manifestations occurre in about 30% of patients. The most common ocular association with rheumatoid arthritis is dry eye syndrome. Other conditi...
Cyclosporin A in the treatment of adult onset Still's disease
Still’s disease is a subset of arthritis which usually appears before the age of 16 (juvenile onset Still’s disease). In subjects who are over 16 it is classified as adult onset Still’s disease. This report describes a 4...
Transverse myelitis in a patient with systemic lupus erythematosus - case report
We report a case of a 20-year-old women diagnosed as systemic lupus erythematosus (SLE) with central nervous system involvement. She suffered from aseptic meningitis followed by transverse myelitis. The treatment with...
A 6-month trial assessing the safety and efficacy of cyclosporine treatment in patients with active rheumatoid arthritis
Objective: The objective of this study was to determine efficacy and safety of the new generic cyclosporin formulation, Equoral capsules administered in monoterapia or in combination with other disease-modifying anti-rhe...
Preliminary data concerning methodology of assessment of serum autoantibodies not included into CTS-s diagnostic criteria
Authors are presenting preliminary data introducing a new way of complex analysis of the sera (ANA-positive but without estimated certain specificity), using for the neutralization and removing of “masking” (competing) a...